Pulmonary thrombosis in the mouse following intravenous administration of quantum dot-labeled mesenchymal cells

Nanotoxicology

Volumn 4, Issue 1, 2010, Pages 98-105

  Ramot, Yuval ^a   Steiner, Michal ^b   Morad, Vered ^b   Leibovitch, Sigalit ^b   Amouyal, Netanel ^b   Cesta, Mark F ^c   Nyska, Abraham ^d  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b Harlan Biotech Israel Limited   (Israel)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Mesenchymal stem cells; NOD SCID mouse; Pulmonary thrombosis; Quantum dots

Indexed keywords

QUANTUM DOT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INFLAMMATION; LUNG THROMBOSIS; MALE; MESENCHYME CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; THROMBOSIS;

ANIMALS; CELL TRANSPLANTATION; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED NOD; MICE, SCID; PULMONARY ARTERY; PULMONARY EMBOLISM; QUANTUM DOTS;

ANIMALIA; MUS;

EID: 77749315431     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390903470093     Document Type: Article

References (35)

1. Akerman ME, Chan WC, Laakkonen P, Bhatia SN, Ruoslahti E. 2002. Nanocrystal targeting in vivo. Proc Natl Acad Sci USA 99(20):12617-12621.
2. Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, Waggoner AS. 2004. Noninvasive imaging of quantum dots in mice. Bioconjug Chem 15(1):79-86.
3. Chan WC, Maxwell DJ, Gao X, Bailey RE, Han M, Nie S. 2002. Luminescent quantum dots for multiplexed biological detection and imaging. Curr Opin Biotechnol 13(1):40-46.
4. Chen F, Gerion D. 2004. Fluorescent CdSe/ZnS nanocrystalpeptide conjugates for long-term, nontoxic imaging and nuclear targeting in living cells. Nano Lett 4(10):1827-1832.
5. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, Bawendi MG, Frangioni JV. 2007. Renal clearance of quantum dots. Nat Biotechnol 25(10):1165-1170.
6. Derfus A, Chan W, Bhatia S. 2004. Probing the cytotoxicity of semiconductor nanocrystals. Nano Lett 4(1):11-18.
7. Ernst H, Dungrowth D, Kamilo K, Rittinghausen S, Mohr U. 1996. Nonneoplastic lesions in the lungs. In: Mohr U, Dungrowth D, Capen C, Carlton W, Sundberg J, Ward J, editors. Pathobiology of the aging mouse. Vol.1. Washington, DC: ILSI Press. pp 281-300.
8. Esmon CT. 2005. The interactions between inflammation and coagulation. Br J Haematol 131(4):417-430.
9. Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, Laine GA, Cox CS Jr. 2009. Pulmonary passage is a major obstacle for intravenous stem cell delivery: The pulmonary first-pass effect. Stem Cells Dev 18(5): 683-692.
10. Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI. 2001. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 169(1):12-20.
11. Geys J, Nemmar A, Verbeken E, Smolders E, Ratoi M, Hoylaerts MF, Nemery B, Hoet PH. 2008. Acute toxicity and prothrombotic effects of quantum dots: Impact of surface charge. Environ Health Perspect 116(12):1607-1613.
12. Gopee NV, Roberts DW, Webb P, Cozart CR, Siitonen PH, Warbritton AR, Yu WW, Colvin VL, Walker NJ, Howard PC. 2007. Migration of intradermally injected quantum dots to sentinel organs in mice. Toxicol Sci 98(1):249-257.
13. Han M, Gao X, Su JZ, Nie S. 2001. Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules. Nat Biotechnol 19(7):631-635.
14. Hardman R. 2006. A toxicologic review of quantum dots: Toxicity depends on physicochemical and environmental factors. Environ Health Perspect 114(2):165-172.
15. Hoet PH, Nemmar A, Nemery B. 2004. Health impact of nanomaterials? Nat Biotechnol 22(1):19.
16. Hoshino A, Fujioka K, Oku T, Suga M, Sasaki Y, Ohta T, Yasuhara M, Suzuki K, Yamamato K. 2004a. Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification. Nano Lett 4(11): 2163-2169.
17. Hoshino A, Hanaki K, Suzuki K, Yamamoto K. 2004b. Applications of T-lymphoma labeled with fluorescent quantum dots to cell tracing markers in mouse body. Biochem Biophys Res Commun 314(1):46-53.
18. Hsieh SC, Wang FF, Hung SC, Chen YJ, Wang YJ. 2006. The internalized CdSe/ZnS quantum dots impair the chondrogenesis of bone marrow mesenchymal stem cells. J Biomed Mater Res B Appl Biomater 79(1):95-101.
19. Jaiswal JK, Mattoussi H, Mauro JM, Simon SM. 2003. Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat Biotechnol 21(1):47-51.
20. Kim S, Lim YT, Soltesz EG, De Grand AM, Lee J, Nakayama A, Parker JA, Mihaljevic T, Laurence RG, Dor DM, Cohn LH, Bawendi MG, Frangioni JV. 2004. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 22(1):93-97.
21. Larson DR, Zipfel WR, Williams RM, Clark SW, Bruchez MP, Wise FW, Webb WW. 2003. Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science 300(5624):1434-1436.
22. Lin S, Xie X, Patel MR, Yang YH, Li Z, Cao F, Gheysens O, Zhang Y, Gambhir SS, Rao JH, Wu JC. 2007. Quantum dot imaging for embryonic stem cells. BMC Biotechnol 7:67.
23. Lovric J, Bazzi HS, Cuie Y, Fortin GR, Winnik FM, Maysinger D. 2005. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J Mol Med 83(5):377-385.
24. Muller-Borer BJ, Collins MC, Gunst PR, Cascio WE, Kypson AP. 2007. Quantum dot labeling of mesenchymal stem cells. J Nanobiotechnol 5:9.
25. Oberdörster G, Oberdörster E, Oberdörster J. 2005. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113(7):823-839.
26. Ramot Y, Nyska A. 2007. Drug-induced thrombosis - experimental, clinical, and mechanistic considerations. Toxicol Pathol 35(2): 208-225.
27. Rehm S, Wcislo A, Deerberg F. 1985. Non-neoplastic lesions of female virgin Han:NMRI mice, incidence and influence of food restriction throughout life span. II: Respiratory tract. Lab Anim 19(3):224-235. (Pubitemid 15071959)
28. Rouse JG, Haslauer CM, Loboa EG, Monteiro-Riviere NA. 2008. Cyclic tensile strain increases interactions between human epidermal keratinocytes and quantum dot nanoparticles. Toxicol In Vitro 22(2):491-497.
29. Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA. 2007. Surface coatings determine cytotoxicity and irritation potential of quantum dot nanoparticles in epidermal keratinocytes. J Invest Dermatol 127(1):143-153.
30. Seleverstov O, Zabirnyk O, Zscharnack M, Bulavina L, Nowicki M, Heinrich JM, Yezhelyev M, Emmrich F, O'Regan R, Bader A. 2006. Quantum dots for human mesenchymal stem cells labeling. A size-dependent autophagy activation. Nano Lett 6(12): 2826-2832.
31. Shiohara A, Hoshino A, Hanaki K, Suzuki K, Yamamoto K. 2004. On the cyto-toxicity caused by quantum dots. Microbiol Immunol 48(9):669-675.
32. Tatara Y, Ohishi M, Yamamoto K, Shiota A, Hayashi N, Iwamoto Y, Takeda M, Takagi T, Katsuya T, Ogihara T, Rakugi H. 2009. Macrophage inflammatory protein-1beta induced cell adhesion with increased intracellular reactive oxygen species. J Mol Cell Cardiol 47(1):104-111.
33. Voura EB, Jaiswal JK, Mattoussi H, Simon SM. 2004. Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nat Med 10(9):993-998.
34. Walker NJ, Bucher JR. 2009. A 21st century paradigm for evaluating the health hazards of nanoscale materials? Toxicol Sci 110(2):251-254.
35. Yang RS, Chang LW, Wu JP, Tsai MH, Wang HJ, Kuo YC, Yeh TK, Yang CS, Lin P. 2007. Persistent tissue kinetics and redistribution of nanoparticles, quantum dot 705, in mice: ICPMS quantitative assessment. Environ Health Perspect 115(9): 1339-1343.